Cerulean Pharma Inc.
Company
Management Team
Board of Directors
Advisors
Investors
Collaborators
Careers
Nanopharmaceuticals
Platform Overview
Supporting Research
Pipeline
CRLX101
CRLX301
siRNA Delivery Program
News
Media Kit
Winning the Fight Against Cancer with Dynamically Tumor-targeted Nanopharmaceuticals.
Cerulean’s nanopharmaceuticals are taken up into tumor cells, where they release their payload. Nanopharmaceuticals are shown in green and tumor cell nuclei in blue.